Health ❯ Medicine ❯ Oncology

Cancer Treatment

Immunotherapy Chemotherapy Pancreatic Cancer Targeted Therapy Ferroptosis Leukemia Antibody-Drug Conjugates CAR-T Cell Therapy Glioblastoma Drug Resistance

Daraxonrasib Doubles Survival in Phase 3 Trial of Treated Metastatic Pancreatic Cancer

An oral KRAS inhibitor that raised median survival to 13.2 months is now available through an FDA expanded access program pending formal review

Single‑Cell Platform Maps How Stromal Barriers Block Antibody Drugs in Solid Tumors

Personalized mRNA Vaccine Halves Five‑Year Melanoma Recurrence Risk

Daraxonrasib Doubles Survival in Treated Metastatic Pancreatic Cancer in Phase 3 Trial

Akari’s AKTX-101 Shows Preclinical Synergy With KRAS Inhibitor as Stock Soars

CRISPR Enzyme Cas12a2 Selectively Destroys Cells Based on RNA in Lab Tests

New CAR-T Designs Deliver Low-Dose Remissions and Expose a Senescence Risk

Single CAR T Infusion Clears Residual Disease in High-Risk Smoldering Myeloma Trial

Experimental Drug Elraglusib Extends Survival in Phase 2 Pancreatic Cancer Trial

Ultrasound-Activated Nanobubbles Break Tumor Barriers in Mouse Study

Southampton Team Engineers Four-Pronged Antibodies to Boost T‑Cell Activation in Preclinical Cancer Tests

Study Finds CBD–THC Combination Kills Ovarian Cancer Cells in Lab

Nasal Nanodrops Activate STING to Eliminate Glioblastoma in Mice

Targeted Nanoparticles Help Checkpoint Drugs Erase Ovarian Tumors in Mice

mRNA COVID Vaccination Linked to Longer Survival With Cancer Immunotherapy, Data Presented at ESMO

Google and Yale Release 27B-Parameter Cell AI After Lab Confirms Interferon-Conditional Antigen Boost

Engineered CAR-T Cells Target PD-L1 to Deliver IL-12 at Tumors, Showing Solid-Tumor Gains in Mice

Genmab to Buy Merus for $8 Billion to Secure Petosemtamab Cancer Drug

Low-Dose Aspirin Halves Recurrence in PI3K-Altered Colorectal Cancer, NEJM Trial Finds

FAP-Targeted Radioligand Yields Near-Complete Response in Three Solitary Fibrous Tumor Patients